BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25913514)

  • 1. Percutaneous Treatment of Large Venous Malformations in the Oral and Maxillofacial Regions Using Electrochemical Therapy Combined With Pingyangmycin.
    Xue L; Cao RY; Xu DP; Sun NN; Tan HS; Wang XK
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1384-91. PubMed ID: 25913514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
    Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional injection of Pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients.
    Zheng JW; Yang XJ; Wang YA; He Y; Ye WM; Zhang ZY
    Oral Oncol; 2009 Oct; 45(10):872-6. PubMed ID: 19628423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin.
    Liu Y; Liu D; Wang Y; Zhang W; Zhao F
    J Oral Maxillofac Surg; 2009 Jan; 67(1):98-104. PubMed ID: 19070754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate.
    Zhao JH; Zhang WF; Zhao YF
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):463-6. PubMed ID: 15183410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study of fibrin glue combined with pingyangmycin for the treatment of venous malformations in the oral and maxillofacial region.
    Yang Y; Sun M; Hou R; Yan Z; Wang L; Cheng X; Lei D; Liu Y
    J Oral Maxillofac Surg; 2008 Nov; 66(11):2219-25. PubMed ID: 18940483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrochemical therapy combined with pingyangmycin injection in the management of high-return flow venous malformation].
    Wei JJ; Li QJ; Xue L; Jin ZL; Yuan WL; Wang XK
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Mar; 47(3):160-3. PubMed ID: 22800669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical study of pingyangmycin sclerotherapy for venous malformation: an evaluation of 281 consecutive patients.
    Bai N; Chen YZ; Fu YJ; Wu P; Zhang WN
    J Clin Pharm Ther; 2014 Oct; 39(5):521-6. PubMed ID: 24924412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with intralesional hemorrhage in venous malformations: diagnosis and embolosclerotherapy.
    Chen H; Lin X; Jin Y; Li W; Ma G; Hu X
    J Vasc Surg; 2009 Feb; 49(2):429-33; discussion 433-4. PubMed ID: 18945573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mattress cerclage combined with electrochemical therapy and pingyangmycin injection after embolization for management of arteriovenous malformation on oral and maxillofacial region.
    Cheng C; Xi SL; Xu DP; Zhai QK; Gong H; Wang XK
    J Craniofac Surg; 2015 Mar; 26(2):e110-3. PubMed ID: 25759930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined injection of pingyangmycin & dexamethasone for the treatment of maxillofacial and cervical venous malformations].
    Zhai J; Zhai XD
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 May; 28(3):168-71. PubMed ID: 22870701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
    Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
    J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous treatment of orofacial vascular malformations.
    Sindel A; Sayan A; Özgür Ö; Sindel T; Ilankovan V
    Br J Oral Maxillofac Surg; 2018 Apr; 56(3):206-211. PubMed ID: 29422307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical study of using Pingyangmycin of high concentration to treat vascular malformation in oral and maxillofacial region].
    Gong DD; Wang XK
    Shanghai Kou Qiang Yi Xue; 2009 Oct; 18(5):483-5. PubMed ID: 19907853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
    Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
    Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional copper wire retention and pingyangmycin injection: an effective combinational therapy for complex venous malformation in soft tissue.
    Yuan SM; Hong ZJ; Jiang HQ; Wang J; Hu XB
    Phlebology; 2014 Apr; 29(3):179-85. PubMed ID: 23508003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions.
    Bai Y; Jia J; Huang XX; Alsharif MJ; Zhao JH; Zhao YF
    J Oral Maxillofac Surg; 2009 Feb; 67(2):251-6. PubMed ID: 19138596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pingyangmycin sclerotherapy for infantile hemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients.
    Hou J; Wang M; Tang H; Wang Y; Huang H
    Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1246-51. PubMed ID: 21893396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embolization and sclerotherapy of maxillofacial arteriovenous malformations with the use of fibrin glue combined with pingyangmycin.
    Yan Z; Wei J; Wu W; Yang X; Sun M; Wang W; Yang X; Yang X; Yang Y
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Jul; 130(1):25-31. PubMed ID: 32493683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multidisciplinary approach to treating maxillofacial arteriovenous malformations in children.
    Chen WL; Ye JT; Xu LF; Huang ZQ; Zhang DM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):41-7. PubMed ID: 19464212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.